General Manager for Neuroscience, Dermatology, and Ophthalmology, Merck
RECRUITED BY: Merck CEO Roy Vagelos
EXECS NEED: The courage to do what's right
I got a call from Dr. Vagelos, with the opportunity to be part of his mission" is how Vlad Hogenhuis, MD, introduces his 14-year
career at Merck. Hogenhuis was getting a Wharton MBA at the time, but he has pharma in his blood. Born in the Netherlands
to a long line of physicians—his father developed a migraine drug—he practiced medicine for four years before deciding to
jump to industry.
He's climbed the Merck ladder by crossing from managing to managed care to licensing to R&D strategy. "I had a broad view
early on," he says. Under CEO Dick Clark's new model integrating clinical and commercial, he directs both the late-stage pipeline
and global marketing for a $1.7 billion three-disease franchise. "I have end-to-end accountability," he says. "There's full
alignment of what the sales force does and what we do in marketing and even in Phase III."